VYNE Therapeutics Inc. - VYNE

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$8.151M

QoQ value delta ($000)

+$3.392M (+71.28%)

Implied price effect (QoQ)

+3.0%

Total shares

13,688,032

QoQ shares delta

+5,456,294 (+66.28%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 45 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Nantahala Capital Management, LLC	1,195	2,000,000	0.04%
Lynx1 Capital Management LP	973	1,628,700	0.15%
Shay Capital LLC	962	1,610,242	0.08%
Anson Funds Management LP	742	1,243,106	0.07%
ADAR1 Capital Management, LLC	635	1,063,899	0.04%
T3 Companies, LLC	564	945,000	0.73%
BRAIDWELL LP	547	916,077	0.02%
CITADEL ADVISORS LLC	307	514,443	0.0%
KVP Capital Advisors, LP	299	500,551	0.22%
TWO SIGMA INVESTMENTS, LP	254	426,412	0.0%
ACADIAN ASSET MANAGEMENT LLC	228	381,797	0.0%
GEODE CAPITAL MANAGEMENT, LLC	192	322,711	0.0%
VANGUARD GROUP INC	182	314,545	0.0%
Ikarian Capital, LLC	158	264,912	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	158	264,557	0.0%
VANGUARD FIDUCIARY TRUST CO	109	183,443	0.0%
UBS Group AG	107	179,784	0.0%
TWO SIGMA ADVISERS, LP	94	163,100	0.0%
XTX Topco Ltd	94	158,396	0.0%
Rangeley Capital, LLC	70	118,064	0.07%
JANE STREET GROUP, LLC	57	95,645	0.0%
BOOTHBAY FUND MANAGEMENT, LLC	48	81,371	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	34	57,784	0.0%
STALEY CAPITAL ADVISERS INC	30	51,472	0.0%
BlackRock, Inc.	26	44,405	0.0%